Newsroom

Sorted by: Latest
-

SKYE Deadline: Rosen Law Firm Urges Skye Bioscience, Inc. (NASDAQ: SKYE) Stockholders to Contact the Firm for Information About Their Rights

NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Skye Bioscience, Inc. (NASDAQ: SKYE) between November 4, 2024 and October 3, 2025. Skye is a clinical stage biopharmaceutical company. For more information, submit a form, email attorney Phillip Kim, or give us a call at 866-767-3653. The Allegations: Rosen Law Firm is Investigating the Allegations that Skye Bioscience, Inc. (NASDAQ: SKYE) Misled Investors Regarding its Business Ope...
-

FLY Deadline in 3 Days: Kessler Topaz Meltzer & Check, LLP Reminds Firefly Aerospace Inc. (FLY) Investors of Filing Deadline in Class Action Lawsuit

RADNOR, Pa.--(BUSINESS WIRE)--The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that a securities class action lawsuit has been filed against Firefly Aerospace Inc. (“Firefly”) (NASDAQ: FLY) on behalf of those who purchased or otherwise acquired Firefly: (1) common stock pursuant and/or traceable to the registration statement and related prospectus (collectively, the “Offering Documents”) issued in connection with the company’s IPO conducted on or about August 7, 2025; an...
-

Riassunto: Biocytogen e Acepodia ampliano la collaborazione attraverso uno schema di valutazione basato sulle opzioni per ADC bispecifici e con doppio payload (BsAD2C) primi nella categoria

PECHINO, ALAMEDA, Calif. e TAIPEI, Taiwan--(BUSINESS WIRE)--Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315) e Acepodia (6976:TT), oggi hanno annunciato la firma di un accordo di opzione e licenza finalizzato a permettere la valutazione strutturata di programmi coniugati farmaco-anticorpo bispecifico (BsADC) per promuovere ulteriormente lo sviluppo di coniugati farmaco-anticorpo bispecifico con doppio payload (BsAD2Cs). L'accordo accorda ad Acepodia un'opzio...
-

Biocytogen et Acepodia élargissent leur collaboration grâce à un cadre d'évaluation basé sur les options des ADC bispécifiques à double charge utile (BsAD2C) de première génération

BEIJING et ALAMEDA, Californie et TAIPEI, Taiwan--(BUSINESS WIRE)--Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE : 688796 ; HKEX : 02315) et Acepodia (6976 : TT) ont annoncé aujourd'hui que les entreprises ont conclu un accord d'option et de licence destiné à permettre l'évaluation structurée des programmes de conjugués anticorps-médicament bispécifiques (BsADC) afin de faire progresser le développement de conjugués anticorps-médicament bispécifiques à double charge utile (BsA...
-

Resumen: Biocytogen y Acepodia firman un contrato de opción para fortalecer el desarrollo conjunto de innovadores ADC biespecíficos y de carga dual (BsAD2C)

PEKÍN y ALAMEDA, California, y TAIPÉI, Taiwán--(BUSINESS WIRE)--Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315) y Acepodia (6976:TT) anunciaron hoy la firma de un contrato de opción y licencia con el objetivo de establecer un marco para la evaluación estructurada de programas de conjugados anticuerpo-fármaco biespecíficos (BsADC) y seguir avanzando en el desarrollo de conjugados anticuerpo-fármaco biespecíficos de carga dual (BsAD2C). El acuerdo otorga a Ac...
-

Samenvatting: Biocytogen en Acepodia breiden samenwerking uit door middel van een op opties gebaseerd evaluatiekader voor eersteklas bispecifieke en dual-payload ADC's (BsAD2C)

BEIJING & ALAMEDA, Calif. & TAIPEI, Taiwan--(BUSINESS WIRE)--Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315) en Acepodia (6976:TT) hebben vandaag bekendgemaakt dat zij een optie- en licentieovereenkomst hebben gesloten om een gestructureerde evaluatie van bispecifieke antilichaam-geneesmiddelconjugaatprogramma's (BsADC) mogelijk te maken. Hiermee beogen ze de ontwikkeling van bispecifieke antilichaam-geneesmiddelconjugaten met dubbele lading (BsAD2C's) verd...
-

Biocytogen und Acepodia erweitern Kooperation durch optionsbasiertes Evaluierungsmodell für bispezifische und Dual-Payload-First-in-Class-ADC (BsAD2C)

PEKING, China, ALAMEDA, Kalifornien, USA, und TAIPEH, Taiwan--(BUSINESS WIRE)--Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315) und Acepodia (6976:TT) haben heute den Abschluss einer Options- und Lizenzvereinbarung bekannt gegeben, die eine strukturierte Evaluierung von Programmen für bispezifische Antikörper-Wirkstoff-Konjugate (BsADC) vorsieht, um die Entwicklung von bispezifischen Antikörper-Wirkstoff-Konjugaten mit doppelter Wirkstoffladung (BsAD2Cs) vor...
-

KBRA Assigns Ratings to MidCap Financial Issuer Trust

NEW YORK--(BUSINESS WIRE)--KBRA assigns an issuer rating of A-, a senior unsecured debt rating of A-, and a junior subordinated debt rating of BBB to MidCap Financial Issuer Trust, a wholly-owed subsidiary of MidCap FinCo Intermediate LLC ("the company" or "MidCap"), which serves as guarantor of the debt. MidCap is a commercial financial company that provides senior secured debt solutions to companies across multiple industries. The company is headquartered in Bethesda, MD. The ratings Outlook...
-

WD-40 Company to Participate in the 2026 ICR Conference

SAN DIEGO--(BUSINESS WIRE)--WD‑40 Company (NASDAQ: WDFC) today announced that Steve Brass, president and chief executive officer and Sara Hyzer, vice president, finance and chief financial officer will present at the 28th Annual ICR Conference in Orlando on Tuesday, January 13, 2026, at 10:00 a.m. Eastern Time. A live webcast of this event will be available on the Company’s investor relations website at http://investor.wd40company.com. The event will be archived and available on the website for...
-

USA Truck Returns to Private Ownership with Arkansas-Based UTAC, LLC, Positioned for Accelerated Growth

VAN BUREN, Ark.--(BUSINESS WIRE)--USA Truck is proud to announce a significant and strategic transition to private, Arkansas-based ownership, marking a pivotal new chapter in the company’s more than 40-year history. Following the successful execution of an agreement for DSV to sell 100% of the shares in USA Truck, Inc. to UTAC, LLC, a private entity based in Arkansas, USA Truck officially returns to ownership rooted in the state where its legacy began. The transaction closed today. This return...